Maternal use of certain drugs during pregnancy can result in transient neonatal signs
consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting …

Maternal drug use during pregnancy may result in neonatal withdrawal. This statement
presents current information about the clinical presentation, differential diagnosis …

Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Objective: To identify maternal and neonatal factors that impact response to methadone
therapy for neonatal abstinence syndrome. Study Design: This is a retrospective review of …

Illicit drug use during pregnancy is common and probably underestimated in the majority of
published studies. The infant exposed to opiates or other drugs of dependency during …

Neonates who have had in utero exposures from maternal substance abuse can experience
central nervous system effects of the drugs, including drug toxicity and withdrawal. Neonatal …

Neonatal Abstinence Syndrome | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

OBJECTIVE: The objective of the study was to identify maternal variables predicting length
of treatment for neonatal abstinence syndrome (NAS). STUDY DESIGN: This was a …

OBJECTIVE To Address challenges in clinical care, quality improvement, research, and
public policy for prenatally opioid-exposed neonates by standardizing the clinical definition …

OBJECTIVE. The purpose of this research was to assess the effects of breast milk on the
severity and outcome of neonatal abstinence syndrome. METHODS. We conducted a …